About Us

Jiangsu SinoExci BioPharma Co., Ltd., established in 2023, is a research- and manufacturing-oriented enterprise invested by the shareholders of RON Pharm. The company is dedicated to the development and production of high-end, innovative pharmaceutical excipients, with a strong focus on functional performance and application research of excipients in pharmaceutical formulations.                            SinoExci is committed to providing pharmaceutical manufacturers with differentiated, functional, and specialty high-value excipients.

Through localized production in China, the company aims to ensure supply security and technical independence for high-end and specialty drug delivery systems.                            Manufacturing operations are strictly organized in compliance with GMP requirements. Products are designed to meet the standards of major international pharmacopoeias, includingChP, USP, EP, and JP.                            Driven by market demand, SinoExci adopts a market-oriented innovation strategy and continuously enhances its R&D capabilities.                            With strong technical expertise and advanced research conditions, SinoExci places particular emphasis on the development and application of new formulations, novel drug delivery technologies, and innovative excipient materials.                            By leveraging its partners’ strong market access and application development capabilities within pharmaceutical excipient market, SinoExci actively supports the commercialization of generic drugs and high-end innovative R&D projects.